Petmed Express (NASDAQ:PETS) posted its earnings results on Monday. The company reported $0.26 EPS for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.16), Briefing.com reports. Petmed Express had a return on equity of 28.96% and a net margin of 13.32%. The company had revenue of $79.99 million during the quarter, compared to the consensus estimate of $85.83 million. During the same period last year, the firm posted $0.62 EPS. The company’s revenue for the quarter was down 8.5% on a year-over-year basis.
Shares of Petmed Express stock opened at $16.03 on Tuesday. The company has a market cap of $328.23 million, a P/E ratio of 8.82 and a beta of 0.52. The business has a fifty day moving average price of $16.34. Petmed Express has a fifty-two week low of $15.00 and a fifty-two week high of $38.90.
The company also recently announced a quarterly dividend, which will be paid on Friday, August 9th. Investors of record on Friday, August 2nd will be issued a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 6.74%.
A number of institutional investors have recently modified their holdings of PETS. American Century Companies Inc. purchased a new stake in shares of Petmed Express during the 4th quarter valued at about $6,088,000. Deutsche Bank AG raised its position in shares of Petmed Express by 166.1% during the 4th quarter. Deutsche Bank AG now owns 329,962 shares of the company’s stock valued at $7,673,000 after buying an additional 205,960 shares in the last quarter. LSV Asset Management grew its holdings in Petmed Express by 35.0% during the 1st quarter. LSV Asset Management now owns 762,337 shares of the company’s stock valued at $17,366,000 after purchasing an additional 197,550 shares during the last quarter. Inlet Private Wealth LLC grew its holdings in Petmed Express by 1,333.6% during the 2nd quarter. Inlet Private Wealth LLC now owns 153,400 shares of the company’s stock valued at $2,315,000 after purchasing an additional 142,700 shares during the last quarter. Finally, Rothschild Investment Corp IL bought a new position in Petmed Express during the 1st quarter valued at about $2,668,000. 95.04% of the stock is owned by institutional investors.
About Petmed Express
PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.
See Also: What are municipal bonds?
Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.